Sector: health
Conviction from: NASDAQS&P
52-week range: 160.36261.00
Biogen is a biopharmaceutical company focused on neuroscience, developing treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease.
4 tracked filer(s) hold this · 1 opened, 2 added, 1 trimmed in 30-SEP-2026
Aggregate 13FScore 60 — mean of 4 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
4 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-08-22 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |